查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
紅色生物技術市場 - 2018-2028 年全球產業規模、佔有率、趨勢、競爭、機會和預測，按產品類型、應用、最終用戶和地區分類
市場調查報告書
商品編碼
1309231

紅色生物技術市場 - 2018-2028 年全球產業規模、佔有率、趨勢、競爭、機會和預測，按產品類型、應用、最終用戶和地區分類

Red Biotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product Type, By Application, By End-User, By Region
出版日期: | 出版商: TechSci Research | 英文 78 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2024-2028 年的預測期內，全球紅色生物技術市場預計將以驚人的複合年成長率成長。這主要歸因於對基因工程的需求不斷成長、用於治療危及生命的疾病的新藥開發以及精準醫療產量的增加等因素。

基因工程需求不斷成長

由於生物藥物的增加，對基因工程的需求也在增加。根據IQVIA 研究所的數據，生物藥占美國所有處方藥的2%，但卻佔藥品支出淨額的37%。基因工程（如重組DNA 技術）在製造基因改造生物（如治療性抗體）中的應用日益廣泛，推動了全球紅色生物技術市場的成長。基因編輯（如基於CRISPR 的基因編輯）等技術在市場上也越來越普遍，從而通過擴大紅色生物技術在基因工程中的應用支持了市場的成長。此外，通過組織工程技術，紅色生物技術還可應用於生產椎間盤、人造骨骼、皮膚和軟骨。

開發治療危及生命疾病的新藥

紅色生物技術可應用於基因治療、臨床試驗、診斷和研究等領域。此外，為開發藥物而進行的臨床試驗數量不斷增加，以及對生物學名藥的接受度和需求的上升，也影響了紅色生物技術近期的發展。隨著藥品生產中臨床試驗的不斷增加，預計紅色生物技術市場的生物製藥領域將不斷擴大。例如，2022 年7 月，Replay - 一家基因組藥物生產初創公司在種子輪融資中投資了5500 萬美元，通過開發各種基因型基因組研究的相互聯繫階段來發展和改造基因組醫學，從而發現新的疾病靶點，加強和改善疾病的診斷和治療。

精準醫療產量增加

全球慢性病發病率不斷上升，對精準醫療的需求也在不斷增加。據世界衛生組織（WHO）統計，癌症是全球第二大死因，全球約有960 萬人死於癌症。隨著全球癌症患者人數的不斷增加，紅色生物技術市場的成長也在不斷擴大，因為它可通過基因檢測和測序技術等用於診斷這些疾病的原因，從而在癌症等疾病的診斷、藥物開發和治療方面發現了許多有利可圖的機會，因此預計在預測期內將促進市場成長。此外，紅色生物技術還被用於聯合疫苗的生產，如乙型肝炎疫苗與脊髓灰質炎疫苗的合併，以及白百破疫苗與甲型肝炎疫苗的合併，這些都對支持預測期內的市場成長具有重要意義。

最新進展

2022 年6 月，Bluebird Bio 開發出一種新型基因療法，該療法正在接受美國食品藥品管理局的評估，用於治療青少年患者的腦腎上腺白質營養不良症（CALD）（一種損害腦膜髓鞘的遺傳疾病）。

可客製化

TechSci Research 可根據給定的市場數據，為公司的特定需求提供客製化服務。報告可提供以下客製化選項：

公司資訊

  • 其他市場參與者（最多五家）的詳細分析和概況。

目錄

第1 章：產品概述

  • 市場定義
  • 市場範圍
    • 市場覆蓋範圍
    • 研究年份
    • 主要市場細分

第2 章：研究方法

  • 研究目標
  • 基準方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第3 章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概述
  • 市場驅動因素、挑戰和趨勢概述

第4 章：客戶之聲

第5章：紅色生物技術市場前景。

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品類型（診斷試劑、人類疫苗、血液製品、基因重組藥物及其他）
    • 按應用（生物製藥生產、基因治療、基因檢測、藥物基因組學、藥物研發及其他）
    • 按最終用戶（製藥和生物技術公司、CMO 和CRO、研究所及其他）
    • 按公司（2022 年）
    • 按地區
  • 產品市場地圖

第6 章: 亞太地區紅色生物技術市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 產品類型
    • 終端用戶
    • 按國家
  • 亞太地區：國家分析
    • 中國.
    • 印度.
    • 印度.
    • 日本
    • 澳大利亞

第7 章: 歐洲紅色生物技術市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 產品類型
    • 終端用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8 章：北美紅色生物技術市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 產品類型
    • 終端用戶
    • 按國家
  • 北美洲：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第9章：南美洲紅色生物技術市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 產品類型
    • 終端用戶
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10 章：中東和非洲紅色生物技術市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 產品類型
    • 終端用戶
    • 按國家
  • 中東和非洲：國家分析
    • 南非紅色生物技術
    • 沙烏地阿拉伯紅色生物技術
    • 阿拉伯聯合大公國紅色生物技術
    • 科威特紅色生物技術

第11 章：市場動態

  • 驅動因素
  • 挑戰

第12 章：市場趨勢與發展

  • 近期動態
  • 合併與收購
  • 產品開發

第13 章：競爭格局

  • 業務概述
  • 公司概況
  • 產品與服務
  • 財務狀況（上市公司）
  • 近期發展
  • SWOT 分析
    • Pfizer, Inc.
    • Takeda Pharmaceutical Company Limited
    • Gilead Sciences
    • Regeneron Pharmaceuticals, Inc.
    • F. Hoffmann-La Roche, Ltd.
    • Bruker
    • Merck KGaA
    • Celgene Corporation
    • Amgen, Inc.
    • Biogen, Inc.,

第14 章：戰略建議

簡介目錄
Product Code: 15044

Global Red Biotechnology Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as the growing demand for genetic engineering, the development of new medicines for the treatment of life-threatening diseases, and the increased production of precision medicine.

Red Biotechnology focuses on the therapeutic or diagnostic use of living cells and their components to develop novel medical treatments and cures for diseases and health issues. It includes the creation of a wide range of goods, including medicines, diagnostic instruments, vaccines, gene treatments, and other products for the treatment and prevention of different diseases.

The growing demand for precision medicine is enhancing the market opportunities and increasing demand for the global red biotechnology market.

Growing Demand for Genetic Engineering

An increase in demand for genetic engineering has been observed due to an increase in biologic drugs. According to IQVIA Institute data, biologic drugs represented 2 percent of all United States prescriptions but comprised 37% net drug spending. The growing use of genetic engineering, such as recombinant DNA technology, in creating genetically modified organisms, such as therapeutic antibodies, is propelling the growth of the red biotechnology market across the globe. The technologies, such as gene editing, such as CRISPR-based genetic editing, are also becoming much prevalent in the market and thereby are supporting the market growth by expanding the applications of red biotechnology in genetic engineering. Additionally, red biotechnology is found to have applications in the production of spinal discs, artificial bones, skin, and cartilage through tissue engineering techniques.

Development of new medicines for the treatment of life-threatening diseases

Red biotechnology has found applications in fields such as gene therapy, clinical trials, diagnostics, and research. Also, the growing number of clinical trials for the development of drugs, along with the rise in acceptance and demand for biosimilars, affect the growth of red biotechnology in the recent scenario. The expansion of the biopharmaceutical sector of the red biotechnology market is expected to grow with increasing clinical trials in medicine production. For instance, In July 2022, Replay-a genomic medicine-producing startup, invested USD55 million in a seed funding round to develop and transform genomic medicine through an interlinking stage for developing various genotype genomic research to discover new disease targets and enhance and improve the disease diagnosis & treatment.

Increased production of precision medicine

The growing prevalence of chronic diseases across the world is creating a rising demand for precision medicine. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and has recorded around 9.6 million deaths globally. With the increasing number of cancer patients worldwide, the growth of the red biotechnology market is also expanding as it is utilized for diagnosing the reason for these diseases by using genetic testing and sequencing techniques, etc., and thereby has found many lucrative opportunities in diagnosis, drug development and treatment for diseases such as cancer and is thereby expected to bolster market growth in the forecast period. Along with this, red biotechnology is utilized in combined vaccine production, such as Hepatitis B, merged with the polio vaccine, and DPT merged with Hepatitis A, and this all together is of great importance to support the market growth in the forecast period.

Recent Developments

In June 2022, Bluebird Bio developed a new gene therapy that is being evaluated by the United States Food Drug and Administration regarding the treatment of (CALD) cerebral adrenoleukodystrophy (a genetic condition that damages the membrane myelin sheath of the brain) in patients under adolescent age.

Market Segmentation

Global Red Biotechnology Market is segmented based on the product type, application, end-user, region, and competitive landscape. Based on product type, the market is segmented into diagnostic reagents, human vaccines, blood products, gene recombinant drugs, and others. Based on application, the market is segmented into biopharmaceutical production, gene therapy, genetic testing, pharmacogenomics, drug discovery, and others. Based on end-user, the market is segmented into pharmaceutical and biotechnology companies, CMO & CRO, research institutes, and others.

Market Players

Pfizer, Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche, Ltd., Bruker, Merck KGaA, Celgene Corporation, Amgen, Inc., etc., are some of the major players operating in the Global Red Biotechnology Market.

Report Scope

In this report, Global Red Biotechnology Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Red Biotechnology Market, By Product Type:

  • Diagnostic Reagents
  • Human Vaccines
  • Blood Products
  • Gene Recombinant drugs
  • Others

Red Biotechnology Market, By Application:

  • Biopharmaceutical Production
  • Gene Therapy
  • Genetic Testing
  • Pharmacogenomics
  • Drug Discovery
  • Others

Red Biotechnology Market, By End-User:

  • Pharmaceutical and Biotechnology companies
  • CMO & CRO
  • Research Institute
  • Others

Red Biotechnology Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Red Biotechnology Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Red Biotechnology Market Outlook.

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs and Others)
    • 5.2.2. By Application (Biopharmaceutical Production, Gene Therapy, Genetic Testing, Pharmacogenomics, Drug Discovery, and Others)
    • 5.2.3. By End-User (Pharmaceutical and Biotechnology companies, CMO & CRO, Research Institute and Others)
    • 5.2.4. By Company (2022)
    • 5.2.5. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Red Biotechnology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. Product Type
    • 6.2.2. End-User
    • 6.2.3. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Red Biotechnology Market Outlook.
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. Product Type
        • 6.3.1.2.2. End-User
    • 6.3.2. India Red Biotechnology Market Outlook.
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. Product Type
        • 6.3.2.2.2. End-User
    • 6.3.3. South Korea Red Biotechnology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. Product Type
        • 6.3.3.2.2. End-User
    • 6.3.4. Japan Red Biotechnology Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. Product Type
        • 6.3.4.2.2. End-User
    • 6.3.5. Australia Red Biotechnology Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. Product Type
        • 6.3.5.2.2. End-User

7. Europe Red Biotechnology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Product Type
    • 7.2.2. End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Red Biotechnology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Product Type
        • 7.3.1.2.2. End-User
    • 7.3.2. Germany Red Biotechnology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Product Type
        • 7.3.2.2.2. End-User
    • 7.3.3. United Kingdom Red Biotechnology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Product Type
        • 7.3.3.2.2. End-User
    • 7.3.4. Italy Red Biotechnology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Product Type
        • 7.3.4.2.2. End-User
    • 7.3.5. Spain Red Biotechnology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Product Type
        • 7.3.5.2.2. End-User

8. North America Red Biotechnology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Product Type
    • 8.2.2. End-User
    • 8.2.3. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Red Biotechnology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Product Type
        • 8.3.1.2.2. End-User
    • 8.3.2. Mexico Red Biotechnology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Product Type
        • 8.3.2.2.2. End-User
    • 8.3.3. Canada Red Biotechnology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Product Type
        • 8.3.3.2.2. End-User

9. South America Red Biotechnology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Product Type
    • 9.2.2. End-User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Red Biotechnology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Product Type
        • 9.3.1.2.2. End-User
    • 9.3.2. Argentina Red Biotechnology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Product Type
        • 9.3.2.2.2. End-User
    • 9.3.3. Colombia Red Biotechnology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Product Type
        • 9.3.3.2.2. End-User

10. Middle East and Africa Red Biotechnology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Product Type
    • 10.2.2. End-User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Red Biotechnology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Product Type
        • 10.3.1.2.2. End-User
    • 10.3.2. Saudi Arabia Red Biotechnology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Product Type
        • 10.3.2.2.2. End-User
    • 10.3.3. UAE Red Biotechnology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Product Type
        • 10.3.3.2.2. End-User
    • 10.3.4. Kuwait Red Biotechnology Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. Product Type
        • 10.3.4.2.2. End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (In case of listed companies)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. Pfizer, Inc.
    • 13.6.2. Takeda Pharmaceutical Company Limited
    • 13.6.3. Gilead Sciences
    • 13.6.4. Regeneron Pharmaceuticals, Inc.
    • 13.6.5. F. Hoffmann-La Roche, Ltd.
    • 13.6.6. Bruker
    • 13.6.7. Merck KGaA
    • 13.6.8. Celgene Corporation
    • 13.6.9. Amgen, Inc.
    • 13.6.10. Biogen, Inc.,

14. Strategic Recommendations